Ryan Specialty (NYSE:RYAN – Get Free Report) had its target price decreased by investment analysts at UBS Group from $59.00 to $51.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s target price indicates a potential upside of 72.15% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. JPMorgan Chase & Co. dropped their target price on shares of Ryan Specialty from $49.00 to $43.00 and set an “underweight” rating for the company in a research report on Thursday, April 9th. Royal Bank Of Canada started coverage on Ryan Specialty in a research report on Tuesday, March 17th. They set an “outperform” rating and a $45.00 price objective for the company. Wells Fargo & Company lowered Ryan Specialty from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $42.00 to $31.00 in a research report on Friday. Citigroup decreased their price target on shares of Ryan Specialty from $55.00 to $50.00 and set a “buy” rating for the company in a research note on Monday. Finally, Barclays decreased their price target on shares of Ryan Specialty from $41.00 to $39.00 and set an “overweight” rating for the company in a research note on Friday. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $48.12.
Read Our Latest Stock Report on Ryan Specialty
Ryan Specialty Trading Down 3.9%
Ryan Specialty (NYSE:RYAN – Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $0.47 EPS for the quarter, topping the consensus estimate of $0.43 by $0.04. Ryan Specialty had a net margin of 8.21% and a return on equity of 41.33%. The firm had revenue of $795.23 million during the quarter, compared to analysts’ expectations of $781.44 million. During the same period last year, the company posted $0.39 EPS. The company’s quarterly revenue was up 15.2% compared to the same quarter last year. Equities analysts anticipate that Ryan Specialty will post 2.18 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, Director Patrick G. Ryan, Jr. acquired 25,500 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The shares were bought at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the transaction, the director owned 428,295 shares of the company’s stock, valued at $17,114,668.20. This trade represents a 6.33% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 52.03% of the company’s stock.
Institutional Trading of Ryan Specialty
Institutional investors have recently bought and sold shares of the company. Advisory Services Network LLC purchased a new stake in Ryan Specialty during the 3rd quarter valued at about $28,000. Los Angeles Capital Management LLC bought a new position in Ryan Specialty during the 4th quarter valued at about $25,000. SBI Securities Co. Ltd. lifted its stake in Ryan Specialty by 6,322.2% during the 4th quarter. SBI Securities Co. Ltd. now owns 578 shares of the company’s stock valued at $30,000 after acquiring an additional 569 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its stake in Ryan Specialty by 83.7% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 599 shares of the company’s stock valued at $35,000 after acquiring an additional 273 shares during the period. Finally, Fifth Third Bancorp lifted its stake in Ryan Specialty by 65.4% during the 3rd quarter. Fifth Third Bancorp now owns 612 shares of the company’s stock valued at $34,000 after acquiring an additional 242 shares during the period. 84.82% of the stock is owned by hedge funds and other institutional investors.
Ryan Specialty Company Profile
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
See Also
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
